Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
A phase 1/2 trial of Oregovomab, Bevacizumab, Paclitaxel / nab-paclitaxel in ovarian cancer, run by CanariaBio Inc., active and no longer recruiting.
Overview
Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer is a phase 1/2 interventional study registered as NCT04938583 by CanariaBio Inc., with 54 participants planned, started 2021-03-17 and due to reach its primary completion in 2025-10-30. Interventions recorded: Oregovomab, Bevacizumab, Paclitaxel, Carboplatin. Conditions listed: Ovarian Cancer by FIGO Stage, Ovarian Cancer Stage III, Ovarian Cancer Stage IV. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialOregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
Shares Oregovomab, Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.
- TrialOregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
Shares Oregovomab, Ovarian cancer.
- TrialA Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
Shares Oregovomab, Ovarian cancer.
- TrialCATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ov
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.
- TrialPhase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Shares Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.
- TrialA Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer
Shares Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin.
- TrialA Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer
Shares Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin.
- TrialStudy to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or
Shares Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.